Arecor Therapeutics plc (AREC.L)
GBp 69.5
(1.46%)
GBp 69.5
(1.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.55 Million | -10.78 Million | -5.45 Million | -1.85 Million | -458.8 Thousand | -2.5 Million |
| Net Income | -8.55 Million | -10.54 Million | -6.94 Million | -3.51 Million | -2.18 Million | -2.87 Million |
| Depreciation & Amortization | 496 Thousand | 341 Thousand | 171 Thousand | 168.62 Thousand | 151.53 Thousand | 166.93 Thousand |
| Deferred income taxes | - | - | 753 Thousand | 337.65 Thousand | -917.08 Thousand | 5947.00 |
| Stock-based compensation | 638 Thousand | 503 Thousand | 484 Thousand | 318 Thousand | 459.74 Thousand | 200.8 Thousand |
| Change in working capital | 2.17 Million | -1.65 Million | -419 Thousand | 747.27 Thousand | 457.33 Thousand | -23.47 Thousand |
| Other non-cash items | -702 Thousand | 577 Thousand | 506 Thousand | 84.31 Thousand | 662.11 Thousand | 15.39 Thousand |
| Investing Cash Flow | 6.23 Million | -7.99 Million | -68 Thousand | -49.31 Thousand | -22.88 Thousand | -64.55 Thousand |
| Investments in PPE | -151 Thousand | -345 Thousand | -69 Thousand | -52.29 Thousand | -32.29 Thousand | -73.13 Thousand |
| Acquisitions | 5000.00 | 284 Thousand | - | - | - | - |
| Investment purchases | - | -8.04 Million | - | - | - | - |
| Sales/Maturities of investments | 6.38 Million | 8.04 Million | - | - | - | - |
| Other Investing Activities | 6.67 Million | -7.93 Million | 1000.00 | 2976.00 | 9410.00 | 8579.00 |
| Financing Cash Flow | -180 Thousand | 5.16 Million | 20.93 Million | 1.77 Million | -131.01 Thousand | 5.31 Million |
| Debt repayment | -38 Thousand | -295 Thousand | -2.5 Million | -1.84 Million | -87.03 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 6 Million | 20 Million | 423.00 | - | 5.67 Million |
| Other Financing Activities | -15 Thousand | -545 Thousand | 3.42 Million | 3.61 Million | -43.98 Thousand | -353.97 Thousand |
| Accounts receivables | 282 Thousand | -48 Thousand | -1.25 Million | 384 Thousand | 445.94 Thousand | - |
| Accounts payables | 1.37 Million | -2.19 Million | 838 Thousand | 363 Thousand | - | - |
| Inventory | 360 Thousand | 587 Thousand | - | - | 11.38 Thousand | 11.38 Thousand |
| Other working capital | 157 Thousand | - | - | 275.00 | - | -34.86 Thousand |
| Cash at beginning of period | 4.76 Million | 18.31 Million | 2.89 Million | 3.07 Million | 704.94 Thousand | 704.94 Thousand |
| Cash at end of period | 5.09 Million | 4.76 Million | 18.31 Million | 2.89 Million | 3.44 Million | 3.44 Million |
| Capital Expenditure | -151 Thousand | -345 Thousand | -69 Thousand | -52.29 Thousand | -32.29 Thousand | -73.13 Thousand |
| Effect of forex changes on cash | -171 Thousand | 62 Thousand | 5000.00 | -42.94 Thousand | -27.06 Thousand | -5948.00 |
| Net cash flow / Change in cash | 328 Thousand | -13.55 Million | 15.41 Million | -175.22 Thousand | 2.74 Million | 2.74 Million |
| Free Cash Flow | -5.7 Million | -11.12 Million | -5.51 Million | -1.9 Million | -491.1 Thousand | -2.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.32 Million | -2.32 Million | -8.55 Million | -2.01 Million | -2.01 Million | -4.52 Million |
| Depreciation & Amortization | 113 Thousand | 113 Thousand | 496 Thousand | 97.5 Thousand | 93 Thousand | 301 Thousand |
| Deferred income taxes | - | - | - | - | - | -894.5 Thousand |
| Stock-based compensation | 60 Thousand | 60 Thousand | 638 Thousand | 188 Thousand | 188 Thousand | 131.5 Thousand |
| Change in working capital | 321.5 Thousand | 321.5 Thousand | 2.17 Million | 1.2 Million | 1.2 Million | -161 Thousand |
| Other non-cash items | -256 Thousand | -256 Thousand | -702 Thousand | -184.5 Thousand | -180 Thousand | 895 Thousand |
| Investing Cash Flow | 841.5 Thousand | 841.5 Thousand | 6.23 Million | 3500.00 | 3500.00 | 6.34 Million |
| Investments in PPE | -7500.00 | -7500.00 | -151 Thousand | -39 Thousand | -39 Thousand | -73 Thousand |
| Acquisitions | - | - | 5000.00 | 5000.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 1.64 Million | - | 6.38 Million | -40 Thousand | - | 6.42 Million |
| Other Investing Activities | 849 Thousand | 849 Thousand | 6.67 Million | 42.5 Thousand | 42.5 Thousand | 3.29 Million |
| Financing Cash Flow | -32.5 Thousand | -32.5 Thousand | -180 Thousand | -28 Thousand | -28 Thousand | -124 Thousand |
| Debt repayment | -10 Thousand | - | -38 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -32.5 Thousand | -32.5 Thousand | -15 Thousand | -28 Thousand | -28 Thousand | -62 Thousand |
| Accounts receivables | 222 Thousand | 222 Thousand | 282 Thousand | 726.5 Thousand | 726.5 Thousand | -2.45 Million |
| Accounts payables | -352 Thousand | - | 1.37 Million | -1.35 Million | - | 2.72 Million |
| Inventory | 162.5 Thousand | 162.5 Thousand | 360 Thousand | 396.5 Thousand | 396.5 Thousand | -433 Thousand |
| Other working capital | -63 Thousand | -63 Thousand | 157 Thousand | 78.5 Thousand | 78.5 Thousand | - |
| Cash at beginning of period | 5.09 Million | - | 4.76 Million | 6.61 Million | - | 4.76 Million |
| Cash at end of period | 2.52 Million | -1.28 Million | 5.09 Million | 5.09 Million | -758.5 Thousand | 6.61 Million |
| Capital Expenditure | -7500.00 | -7500.00 | -151 Thousand | -39 Thousand | -39 Thousand | -73 Thousand |
| Effect of forex changes on cash | -9500.00 | -9500.00 | -171 Thousand | -23.5 Thousand | -23.5 Thousand | -62 Thousand |
| Net cash flow / Change in cash | -2.56 Million | -1.28 Million | 328 Thousand | -1.51 Million | -758.5 Thousand | 1.84 Million |
| Free Cash Flow | -2.08 Million | -2.08 Million | -5.7 Million | -749.5 Thousand | -749.5 Thousand | -4.32 Million |
WVFC
5085
CAGU
ARYX
WOSSF
600679